about
DNA methylation dynamics in blood after hematopoietic cell transplant.A promoter DNA demethylation landscape of human hematopoietic differentiation.Transient increase in homocysteine but not hyperhomocysteinemia during acute exercise at different intensities in sedentary individualsDNA methylation signatures identify biologically distinct thyroid cancer subtypes.Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort.Prediction of risk of COPD exacerbations by the BODE index.Socioeconomic differences in incidence and relative survival after a first acute myocardial infarction in the Basque Country, Spain.Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors.Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification.Real incidence of diabetes mellitus in a coronary disease population.Long-term mortality follow-up of the ISOLDE participants: causes of death during 13 years after trial completion.Chronic inflammation as predictor of 1-year hospitalization and mortality in elderly population.A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.Female breast cancer in Gipuzkoa: prognostic factors and survival.[The effect of anchor voices and visible speech in training in the GRABS scale of perceptual evaluation of dysphonia].Prognostic factors in patients with advanced renal cell carcinoma.A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancerUse of phosphate-binding agents is associated with a lower risk of mortalitySupervivencia relativa en cáncer de mama después de la primera recidiva y factores pronóstico asociados«Esa corporeidad mortal y rosa»: análisis del tiempo libre de enfermedad del cáncer de mama en Gipuzkoa en presencia de riesgos competitivos[Prognostic indexes of mortality in pediatric intensive care units]Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish populationPredictive factors for response to treatment in patients with advanced renal cell carcinomaOral glucose tolerance test as a tool for patient improvement after percutaneous coronary interventionLong-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factorMitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H[Thrombosis and obstruction associated with central venous lines. Incidence and risk factors]Predicting non-invasive ventilation failure in children from the SpO₂/FiO₂ (SF) ratio
P50
Q34602752-88398A36-784C-412D-89B2-6A848E9EDF8BQ35633573-A9219904-6D09-4042-B38A-A747ED0A880DQ36453842-198EFE9E-16B4-4C29-9725-F5002DBA905DQ39153033-AB3966DD-484D-4D93-BBEE-E4EE56916233Q39850072-AD2324B3-A8D7-4A53-9D6E-6A40C8DDB998Q41999462-F9EFC468-908D-4B5E-A66F-9273CDB14308Q43744852-B0FE6163-00D2-4CE1-AE04-C7BADD767C8BQ44151101-C6511ACA-DE3E-4AB7-A83D-53F117896B3CQ44240409-1BFB0BEA-2EBE-4A15-80A4-BD36160B7807Q45349643-0AF4BF00-7C01-428F-B653-F16CB1DE690EQ46487950-D3219395-85BE-4936-A8F2-40B4AC48CD2DQ47717970-E534E457-A56B-46F3-87B1-B3AC1682B9D1Q50553399-C49BE52E-5AAE-4A04-ADDA-D8E8A86F1483Q51657225-DE20BD7C-D817-497E-BE0C-91D4A2E334EAQ51837718-F659FF8D-5174-404F-975E-2506E604354AQ54485432-A6CD16C7-A698-4397-B101-344D1452F4F8Q58458546-1DA34FFD-C25B-47ED-BB92-76C015423478Q58946500-5F49DB6C-42B6-4D52-A72A-7DEDDBC63A5BQ61863753-82E2AC90-143B-4AA5-82E6-891766FC6554Q61863757-C97C041B-2B99-47C3-91FE-B55C8F88507FQ80150421-990A70FC-ABC5-4329-B32F-3D5C348AEF93Q84095460-CC5E36A4-F7AD-4E74-9C62-98A676A240C6Q84241662-CF787853-3A59-4A5B-89F7-27F5D68E16C6Q84442635-2CDB0B3B-13C6-4707-B622-0385F1008ACFQ84985120-33DBC31F-CE7C-49BE-929E-04D26BBAB3ACQ85072600-F15AD6CC-C640-4BB1-8B00-7FEF99C47305Q86179592-DB9FCF5F-D4E1-42B1-BE74-002CE7BD8F30Q86494273-9A5E8A53-BC94-46EA-B5C4-E4C95FCAC0DA
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pablo Martínez-Camblor
@ast
Pablo Martínez-Camblor
@en
Pablo Martínez-Camblor
@es
Pablo Martínez-Camblor
@nl
Pablo Martínez-Camblor
@sl
type
label
Pablo Martínez-Camblor
@ast
Pablo Martínez-Camblor
@en
Pablo Martínez-Camblor
@es
Pablo Martínez-Camblor
@nl
Pablo Martínez-Camblor
@sl
prefLabel
Pablo Martínez-Camblor
@ast
Pablo Martínez-Camblor
@en
Pablo Martínez-Camblor
@es
Pablo Martínez-Camblor
@nl
Pablo Martínez-Camblor
@sl
P106
P1153
24462229000
P21
P2456
P31
P496
0000-0003-3032-9598
P569
2000-01-01T00:00:00Z